Inquiry Basket
Polymer-Based Protein Delivery Services
Protein Drug Delivery Solutions
BOC Sciences provides polymer-based protein drug delivery solutions for structural stabilization, aggregation control, gentle encapsulation, carrier selection, polymer-protein conjugation, controlled release design, and formulation development from feasibility assessment to prototype evaluation.
Protein Delivery Development Support
Our support connects protein stability requirements with polymer carrier architecture, mild processing strategy, release behavior, and characterization planning.
- Platform selection based on protein size, structure, charge, stability, and release objectives
- Hydrogel, nanogel, nanoparticle, microsphere, microcapsule, matrix, and conjugation options
- Protein loading, encapsulation, aggregation control, and release evaluation
- Optimization guidance for polymer chemistry and stability-preserving formulation design
Why Protein Delivery Requires Stability-Focused Polymer Engineering
Protein delivery development requires careful control of conformational stability, aggregation, adsorption, processing stress, release environment, and analytical interpretation. Unlike small molecules, proteins may lose structural integrity when exposed to unfavorable pH, temperature, shear, organic solvents, air-liquid interfaces, hydrophobic surfaces, or polymer degradation microenvironments.
BOC Sciences supports protein delivery projects by evaluating protein properties, matching polymer materials to stability and release objectives, preparing prototype carriers, and generating characterization data that help guide rational formulation decisions. Our development approach focuses on protecting protein structure while building practical carrier systems for controlled release, local retention, or polymer-assisted stabilization.
Conformational Stability Protection
Protein delivery systems should preserve folded structure and minimize formulation conditions that trigger unfolding or loss of integrity. Polymer chemistry, water content, surface properties, buffer compatibility, and fabrication method all influence protein stability during preparation and release.
Aggregation and Interface Control
Proteins may aggregate at air-liquid, solid-liquid, particle, membrane, or polymer matrix interfaces. Hydrophilic polymer environments, PEG-modified surfaces, gentle processing conditions, and protective matrices can help reduce aggregation-related formulation risks.
Controlled Release Without Structural Compromise
Protein release must be evaluated together with post-release integrity. Hydrogels, nanogels, microspheres, microcapsules, polymer matrices, and conjugation systems can regulate release through diffusion, swelling, degradation, permeability, or linker-based mechanisms.
Common Challenges in Protein Drug Delivery Development
Protein delivery development requires simultaneous management of molecular structure, carrier compatibility, mild processing, release control, and method reliability. BOC Sciences helps identify formulation risks related to protein size, isoelectric point, surface charge, aggregation tendency, thermal sensitivity, solvent exposure, and matrix behavior before carrier development begins.
Protein Denaturation During Processing
Temperature changes, organic solvents, shear, emulsification, drying, or interfacial exposure can disrupt protein folding and reduce structural integrity.
Aggregation and Particle Formation
Protein aggregation may occur during preparation, storage, release, or reconstitution, affecting formulation uniformity and data interpretation.
Adsorption Loss at Interfaces
Proteins may adsorb to containers, membranes, particles, air-liquid interfaces, or polymer surfaces, reducing recovery and distorting release results.
Low Encapsulation Efficiency
Large molecular size, hydrophilicity, charge distribution, and structural complexity may limit protein incorporation into polymer carriers.
Burst Release and Diffusion Limitation
Surface-localized protein may release too quickly, while dense matrices may restrict diffusion and create incomplete release profiles.
Analytical Complexity
Protein delivery studies require attention to quantification, integrity, aggregation, degradation, adsorption, carrier interference, and recovery.
Our Polymer-Based Protein Delivery Platforms
BOC Sciences provides a protein-focused polymer delivery platform portfolio for projects requiring structural protection, aggregation control, gentle encapsulation, sustained release, local retention, and protein-compatible carrier development. Each platform can be selected and customized according to protein molecular weight, isoelectric point, surface charge, aggregation tendency, conformational stability, processing sensitivity, and target release profile.
Hydrogel-Based Protein Delivery Systems
Hydrogel-based systems are suitable for protein projects requiring hydrated microenvironments, local retention, mild formulation conditions, and diffusion-controlled release. These platforms help reduce exposure to hydrophobic interfaces and can be adjusted through polymer composition, crosslinking density, swelling behavior, and network mesh size.
- Suitable for proteins sensitive to harsh processing or hydrophobic interfaces
- Supports hydrated matrix environments and localized release design
- Release behavior can be adjusted by swelling and network structure
- Key evaluations include gelation, protein recovery, diffusion, and stability
Polymer Nanogel Platforms
Polymer nanogels are suitable for proteins requiring nanoscale hydrated carriers, soft network protection, and controlled diffusion behavior. Their crosslinked yet water-rich structures can help accommodate hydrophilic protein payloads while allowing material-level adjustment of swelling, charge interaction, and release behavior.
- Suitable for hydrophilic and structurally sensitive protein payloads
- Provides nanoscale hydrated polymer network environments
- Supports functional group and charge interaction tuning
- Key evaluations include nanogel size, swelling, stability, and release
Polymer Nanoparticle Platforms
Polymer nanoparticle platforms are suitable for protein projects requiring nanoscale carrier formation, surface modification, encapsulation screening, or particulate delivery system development. These systems require careful optimization to reduce protein denaturation, aggregation, adsorption loss, and processing-related instability.
- Suitable for nanoscale protein carrier and surface-engineered systems
- Supports particle size, PDI, zeta potential, and morphology control
- Requires protein-compatible encapsulation and stabilization strategies
- Key evaluations include loading, recovery, aggregation, and release integrity
Biodegradable Microsphere Depot Systems
Biodegradable microsphere systems are suitable for protein projects requiring sustained or depot-like release from polymer matrices. These platforms can extend release duration, but formulation design must carefully address solvent exposure, emulsion stress, acidic degradation microenvironments, burst release, and protein integrity during release.
- Suitable for sustained-release and depot-style protein formulation studies
- Supports biodegradable matrix-based release using erosion and diffusion
- Requires careful control of processing stress and internal microenvironment
- Key evaluations include encapsulation, burst release, degradation, and stability
Polymer Microcapsule and Reservoir Systems
Polymer microcapsule and reservoir systems are suitable for protein projects requiring physical separation, membrane-controlled diffusion, or core-shell carrier architecture. These systems can help regulate protein exposure and release through shell thickness, permeability, mechanical stability, and protein retention behavior.
- Suitable for reservoir-style protein loading and membrane-controlled release
- Supports core-shell architecture and protective compartment design
- Useful when physical separation from external media is needed
- Key evaluations include shell integrity, permeability, leakage, and consistency
Polymer–Protein Conjugation and PEGylation Systems
Polymer–protein conjugation and PEGylation systems are suitable when direct encapsulation is insufficient or when protein behavior needs to be modified at the molecular level. These strategies can support changes in solubility, dispersion, surface properties, stability, and polymer compatibility.
- Suitable for protein systems requiring molecular-level polymer modification
- Supports PEGylation, linker design, and functional polymer conjugation
- Useful when carrier encapsulation causes instability or low recovery
- Key evaluations include conjugation efficiency, structural retention, and data quality
Need Help Designing a Stability-Preserving Protein Delivery System?
Share your protein type, molecular weight, isoelectric point, aggregation behavior, stability concerns, target release duration, preferred delivery format, and available sample amount. We can help evaluate polymer platform options and development steps.
Polymer Material Support for Protein Drug Delivery Development
BOC Sciences supports protein delivery development through polymer material selection, functional modification, formulation-oriented material screening, and carrier compatibility evaluation. Material support is tailored to protein stability requirements, including hydration, surface protection, reduced adsorption, gentle loading, controlled diffusion, matrix compatibility, and release-stage integrity.
Hydrophilic Polymer Networks
Hydrophilic polymer networks support hydrated carrier environments for protein loading, local retention, and diffusion-controlled release. These materials are useful when the project requires reduced hydrophobic interface exposure and protein-compatible formulation conditions.
- PEG, PVA, alginate, chitosan, and related network materials
- Hydrated matrices for protein stability-oriented formulation design
- Swelling, mesh size, crosslinking, and diffusion control
PEG and PEG Derivative Materials
PEG and PEG derivative materials can support protein stabilization, surface modification, polymer conjugation, and carrier compatibility improvement. These materials are frequently considered when reducing adsorption or modifying protein-polymer interactions is important.
- PEG and PEG derivatives for stabilization-focused carrier design
- PEGylated surfaces and polymer-protein conjugation strategies
- Improved dispersion, hydration, and interface protection
Biodegradable Polyester Materials
Biodegradable polyester materials can support protein-loaded nanoparticles, microspheres, depot matrices, and implant-like systems. Their use requires careful evaluation of processing conditions and degradation microenvironments that may affect protein stability.
- Biodegradable polymers for matrix-based release systems
- PLGA, PLA, PCL, and related polyester carrier materials
- Release control through polymer erosion, diffusion, and degradation
Natural Polymer and Polysaccharide-Based Materials
Natural polymers and polysaccharide-based materials can provide hydrated, mild, and network-forming environments for protein formulation development. They may be used in gels, coatings, matrices, or ionically structured carrier systems.
- Natural polymers and derivatives for protein-compatible matrices
- Polysaccharide networks for hydration and local retention
- Mild gelation, coating, and matrix formation options
Functionalized Polymer Materials
Functionalized polymers provide reactive or interactive groups for surface modification, polymer-protein conjugation, carrier stabilization, and interaction control. They are useful when standard polymer materials cannot provide suitable loading or compatibility.
- Side/end group functionalization for polymer carrier design
- Amine-functional polymers and acid-functional polymer options
- Charge, linker, terminal group, and surface chemistry adjustment
Stimuli-Responsive Polymer Materials
Stimuli-responsive polymer materials can support protein release studies involving pH, temperature, redox state, ionic strength, enzymatic exposure, or swelling-dependent behavior. These materials are selected when controlled environmental response is part of the delivery design.
- pH-, temperature-, redox-, enzyme-, or ion-responsive materials
- Trigger-linked swelling, permeability, or degradation behavior
- Responsive networks for controlled protein release exploration
How to Select Polymer Platforms for Different Protein Drugs
Protein drugs often require polymer delivery strategies because they are structurally complex, sensitive to denaturation, prone to aggregation, and vulnerable to enzymatic degradation or rapid clearance. Different protein categories may require different carrier designs, including hydrated matrices for conformational protection, biodegradable particles for sustained release, nanogels for mild encapsulation, or polymer conjugation systems for improved stability and circulation.
| Protein Drugs | Key Delivery Challenges | Suitable Polymer Strategies | Key Evaluation Points |
|---|---|---|---|
| Recombinant Proteins | Conformational sensitivity, short half-life, possible adsorption loss, and limited stability during formulation | Hydrogels, nanogels, PEGylated carriers, mild polymer nanoparticles, biodegradable depot matrices | Protein recovery, aggregation, secondary structure retention, encapsulation efficiency, release integrity, and storage stability |
| Growth Factors | Low-dose activity, rapid degradation, surface adsorption, and need for localized or sustained tissue exposure | Injectable hydrogels, polymer scaffolds, nanogels, microspheres, controlled-release polymer matrices | Bioactivity retention, local release duration, adsorption loss, matrix compatibility, diffusion behavior, and tissue retention |
| Cytokines and Immune Signaling Proteins | High biological potency, systemic toxicity risk, short exposure window, and need for controlled immune modulation | Targeted polymer nanoparticles, hydrogels, nanogels, polymer conjugates, localized depot systems | Dose precision, release kinetics, immune-cell interaction, inflammatory response, carrier biocompatibility, and protein activity |
| Enzyme Drugs | Activity-sensitive structure, active-site protection, proteolytic degradation, and possible immunogenicity concerns | Polymer-enzyme conjugates, nanogels, hydrogels, microcapsules, protective polymer matrices | Enzyme activity retention, structural stability, leakage control, active-site accessibility, degradation resistance, and conjugation efficiency |
| Protein Hormones | Short functional half-life, concentration fluctuation, repeated dosing requirements, and processing-related instability | PLGA microspheres, injectable depots, hydrogels, nanogels, biodegradable polymer implants | Release duration, burst release, hormone activity retention, dose uniformity, protein recovery, and long-term stability |
| Fusion Proteins | Multiple functional domains, complex charge distribution, domain-specific instability, and aggregation risk | Hydrogels, nanogels, PEG-modified carriers, polymer conjugates, surface-stabilized nanoparticles | Domain stability, conformational retention, aggregation behavior, loading efficiency, release profile, and functional activity |
| Protein Vaccine Antigens | Structural presentation requirements, degradation during processing, weak stability, and need for controlled immune exposure | PLGA nanoparticles, polymer microparticles, microneedle matrices, hydrogels, microcapsules, adjuvant-compatible carriers | Antigen integrity, loading distribution, particle size, release timing, adjuvant compatibility, and immune presentation behavior |
| Replacement Therapy Proteins | Need for prolonged exposure, repeated administration burden, stability limitations, and possible immune response | PEGylated protein systems, sustained-release hydrogels, polymer conjugates, microspheres, reservoir-type matrices | Circulation extension, release consistency, protein activity, degradation profile, immunogenicity-related indicators, and formulation reproducibility |
| Protein-Polymer Conjugates | Reactive group accessibility, site selectivity, linker compatibility, altered hydrodynamic size, and activity retention | PEGylation, functional polymer conjugation, degradable linker systems, protein-polymer hybrid carriers | Conjugation efficiency, site distribution, molecular weight profile, dispersity, structural retention, and biological activity |
How We Support Protein Delivery Development
BOC Sciences supports protein delivery projects from early feasibility evaluation through polymer material selection, platform comparison, prototype carrier preparation, protein loading assessment, structural stability evaluation, release testing, and optimization planning. Each service module can be configured around the specific protein type, project stage, available sample amount, analytical method readiness, and target release profile.
Protein Property and Stability Assessment
We evaluate the protein molecule itself to define formulation risk, platform suitability, and analytical requirements before carrier development begins.
- Review protein type, molecular weight, isoelectric point, concentration, and buffer conditions
- Assess aggregation tendency, adsorption risk, thermal sensitivity, and freeze-thaw sensitivity
- Evaluate sensitivity to pH, solvent exposure, shear, interfaces, and drying steps
- Identify analytical requirements for protein integrity, recovery, aggregation, and release testing
Polymer Carrier and Material Selection
We select polymer materials and carrier directions according to protein stability requirements, release objectives, and processing tolerance.
- Screen hydrophilic networks, PEG derivatives, biodegradable polymers, and natural polymer derivatives
- Select materials according to charge interaction, hydrophilicity, degradation behavior, and functional groups
- Evaluate polymer compatibility with protein conformation, aggregation risk, and processing conditions
- Recommend hydrogels, nanogels, nanoparticles, microspheres, microcapsules, or conjugates
Prototype Carrier Preparation
We prepare prototype protein delivery systems while controlling formulation and process variables that may affect structural stability.
- Prepare hydrogel, nanogel, nanoparticle, microsphere, microcapsule, matrix, or conjugate prototypes
- Control pH, ionic strength, protein concentration, polymer ratio, and fabrication conditions
- Reduce destabilizing exposure to organic solvent, high shear, temperature stress, or harsh interfaces
- Document formulation variables to support interpretation of loading, stability, and release behavior
Protein Loading and Encapsulation Optimization
We optimize how proteins enter, remain within, and release from polymer carriers while minimizing aggregation and recovery loss.
- Optimize protein-to-polymer ratio, loading method, buffer system, and carrier preparation sequence
- Improve encapsulation efficiency, protein recovery, distribution uniformity, and leakage control
- Evaluate aggregation, adsorption loss, denaturation risk, and incomplete incorporation during loading
- Compare encapsulation, adsorption, matrix entrapment, reservoir loading, or conjugation strategies
Characterization and Stability Evaluation
We combine carrier characterization with protein stability evaluation to interpret platform performance and development limitations.
- Characterize polymer carriers by size, PDI, zeta potential, morphology, swelling, or shell structure
- Evaluate protein recovery, aggregation, structural integrity, adsorption loss, and formulation stability
- Assess release profiles together with post-release protein integrity and carrier-related interference
- Generate data packages for comparing platform feasibility and identifying formulation limitations
Formulation Refinement and Development Guidance
We translate experimental findings into practical next-step recommendations for materials, carrier structure, and processing conditions.
- Recommend polymer composition, molecular weight, hydrophilicity, crosslinking density, or functional group adjustment
- Suggest carrier redesign, surface modification, buffer optimization, or processing condition refinement
- Identify causes of aggregation, burst release, low loading, poor recovery, or release-stage instability
- Provide next-step recommendations for platform comparison, optimization, or additional characterization
Protein Delivery Development Workflow
Our workflow is designed to translate protein-specific instability risks into a structured delivery development plan. Each step connects protein property assessment with polymer platform selection, material support, prototype preparation, loading analysis, structural stability evaluation, release testing, and practical optimization recommendations.
Protein and Delivery Goal Assessment
We begin by reviewing protein type, molecular weight, isoelectric point, purity, concentration, buffer composition, solubility, known stability profile, aggregation information, desired release duration, preferred dosage form direction, available sample quantity, and current delivery challenge. This step clarifies whether the project primarily requires structural stabilization, aggregation reduction, local retention, sustained release, mild encapsulation, or polymer conjugation.
Stability Risk and Processing Sensitivity Review
The protein is evaluated for sensitivity to temperature, pH, ionic strength, organic solvents, shear, air-liquid interfaces, freeze-thaw cycles, drying steps, and polymer microenvironments. This assessment helps define which fabrication methods may create unacceptable risks and which carrier options are more compatible with preserving protein recovery, structure, and release-stage integrity.
Platform Shortlisting
Candidate platforms are shortlisted according to protein type, size, charge, aggregation tendency, release target, and processing tolerance. Hydrogels may be selected for hydrated local release, nanogels for nanoscale soft networks, nanoparticles for carrier engineering, microspheres for depot-like release, microcapsules for reservoir protection, and conjugates for molecular-level polymer modification.
Polymer Material Selection
Suitable polymer materials are selected based on hydrophilicity, functional groups, degradation behavior, molecular weight, crosslinking potential, surface chemistry, charge interaction, and protein compatibility. Material selection may include PEG derivatives, hydrophilic networks, biodegradable polyesters, natural polymer derivatives, functionalized polymers, or responsive polymer systems depending on the selected platform strategy.
Prototype Formulation Preparation
Initial carrier prototypes are prepared while controlling protein-relevant parameters such as buffer composition, ionic strength, protein concentration, polymer ratio, crosslinking conditions, emulsification intensity, solvent exposure, temperature, and drying or reconstitution steps. Prototype preparation provides practical evidence of carrier formation, protein incorporation, physical stability, and process compatibility.
Loading, Integrity, and Release Testing
Prototype systems are evaluated for protein loading, encapsulation efficiency, recovery, leakage, aggregation, adsorption loss, carrier stability, and in vitro release behavior. Release testing is designed to distinguish actual protein liberation from degradation, carrier interference, incomplete extraction, or adsorption artifacts, while also considering post-release protein integrity whenever suitable methods are available.
Data Interpretation and Stability Mapping
Experimental data are interpreted to determine how polymer material, carrier architecture, fabrication conditions, matrix structure, and release environment affect protein behavior. This stage helps identify whether limitations arise from denaturation, aggregation, low loading, burst release, diffusion restriction, adsorption loss, degradation microenvironment, or analytical interference.
Optimization Recommendations
Based on the collected data, we provide recommendations for polymer composition, molecular weight, functional groups, crosslinking density, surface modification, buffer selection, processing conditions, carrier redesign, release testing setup, and additional characterization. Recommendations are aligned with sample availability, development stage, target release duration, and the client's next formulation decision.
Deliverables for Protein Delivery Projects
Deliverables are tailored to project scope and may include platform selection rationale, polymer material recommendations, prototype carrier systems, protein loading data, stability observations, characterization results, release profiles, and optimization guidance. These outputs help clients compare delivery options and decide whether to refine, expand, or redirect the development strategy.
Protein Delivery Platform Selection Report
Summarizes protein properties, stability risks, candidate platform comparison, material logic, and recommended development direction.
Polymer and Material Recommendation Package
Provides suggested polymer classes, functionalization options, molecular weight considerations, material rationale, and formulation risks.
Prototype Protein Delivery Formulations
May include hydrogels, nanogels, nanoparticles, microspheres, microcapsules, polymer matrices, or conjugate-based systems.
Protein Loading and Encapsulation Data
Includes encapsulation efficiency, loading capacity, protein recovery, leakage observations, adsorption loss, and aggregation findings.
Characterization and Stability Data Package
Provides carrier size, morphology, swelling, degradation, gel behavior, protein integrity, recovery, aggregation, or stability data.
Release Evaluation and Optimization Report
Includes release profiles, burst release observations, protein state interpretation, stability limitations, and refinement recommendations.
Why Choose BOC Sciences for Protein Delivery Solutions
BOC Sciences combines polymer chemistry expertise, carrier engineering capability, protein-sensitive formulation thinking, and characterization support to help clients develop polymer-based delivery systems for structurally sensitive protein payloads. Our approach emphasizes mild processing, compatibility-driven material selection, and data-supported optimization.
Protein-Stability-Focused Platform Design
Platform planning considers protein conformation, aggregation, adsorption, processing sensitivity, and post-release integrity from the beginning.
Broad Polymer Delivery Platform Coverage
We support hydrogels, nanogels, nanoparticles, microspheres, microcapsules, polymer matrices, and polymer-protein conjugates.
Polymer Chemistry and Functional Modification Expertise
Polymer composition, PEGylation, end-group functionality, surface modification, hydrophilicity, crosslinking, and degradation behavior can be considered.
Gentle Processing Strategy Development
We prioritize protein-compatible approaches involving hydrated matrices, mild crosslinking, controlled interfaces, and reduced processing stress.
Integrated Characterization Support
Carrier characterization, protein loading, recovery, aggregation, integrity, and release data help guide formulation decisions.
Flexible Research-Stage Collaboration
Projects can be configured as feasibility assessments, platform comparisons, prototype studies, conjugation programs, or release evaluations.
Frequently Asked Questions
These questions address common considerations for protein delivery platform selection, polymer material support, stability protection, encapsulation, conjugation, release testing, and project preparation.
What are the main challenges in protein drug delivery?
Protein delivery commonly faces conformational instability, aggregation, denaturation, adsorption loss, enzymatic sensitivity, processing-related damage, and release-stage integrity issues. Development should consider protein size, charge, isoelectric point, surface hydrophobicity, buffer compatibility, and polymer microenvironment. Carrier design must protect structure while enabling practical loading and controlled release.
Which polymer platforms are suitable for protein delivery?
Suitable platforms may include hydrogels, nanogels, polymer nanoparticles, biodegradable microspheres, microcapsules, reservoir systems, soft matrices, and polymer-protein conjugates. The best option depends on protein type, molecular size, aggregation tendency, processing tolerance, target release duration, and whether the project prioritizes encapsulation, local retention, or molecular modification.
How can polymer carriers reduce protein aggregation?
Polymer carriers can reduce aggregation by creating hydrated environments, limiting hydrophobic interface exposure, modifying carrier surfaces, using PEG-based materials, or controlling local protein concentration. Aggregation risk should be evaluated during loading, storage, release, and recovery. Material choice, buffer conditions, and processing method all influence protein stability.
Can proteins be encapsulated in biodegradable polymer systems?
Yes, proteins can be explored in biodegradable polymer nanoparticles or microspheres, but formulation conditions must be carefully controlled. Proteins may be sensitive to organic solvents, emulsification stress, drying, acidic degradation microenvironments, or incomplete release. Encapsulation studies should include recovery, aggregation, integrity, loading, and post-release stability evaluation.
When are hydrogels suitable for protein delivery?
Hydrogels are suitable when proteins require hydrated matrices, mild preparation conditions, local retention, or diffusion-controlled release. Their network structure can be adjusted through polymer composition, crosslinking density, swelling behavior, and mesh size. Hydrogels are especially useful when reducing hydrophobic interface exposure is an important formulation goal.
What information is needed to start a protein delivery project?
Useful starting information includes protein type, molecular weight, isoelectric point, concentration, buffer system, purity, stability data, aggregation behavior, target release duration, preferred platform, available sample quantity, and analytical methods. Known sensitivities to temperature, pH, solvent, shear, freeze-thaw, or drying steps are also helpful.
Can protein-polymer conjugation be used instead of encapsulation?
Yes. Protein-polymer conjugation or PEGylation may be considered when encapsulation causes low recovery, aggregation, or instability. Conjugation design should evaluate available reactive groups, linker chemistry, site accessibility, structural retention, dispersity, and characterization methods. It can also complement carrier-based approaches when molecular-level modification is useful.
How is protein stability evaluated during delivery development?
Protein stability can be evaluated through recovery, aggregation, integrity, degradation products, adsorption loss, release-stage condition, and carrier interference assessment. The exact method depends on the protein and platform. Stability evaluation should separate true protein instability from extraction loss, assay interference, incomplete release, or adsorption to test materials.
Submit Your Drug Delivery Project Inquiry
Please share your protein type, molecular weight, isoelectric point, concentration, buffer conditions, stability profile, aggregation concerns, target release duration, preferred platform, available sample amount, and current formulation challenge. Our team can help propose a suitable polymer-based protein delivery strategy.
- Polymer carrier selection for protein delivery
- Protein encapsulation, stabilization, and aggregation control
- Hydrogel, nanogel, nanoparticle, microsphere, microcapsule, and matrix systems
- PEGylation, protein-polymer conjugation, and functional carrier design
- Characterization, protein loading, stability evaluation, and release testing
